loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Salmeterol Xinafoate

    Menu

    Salmeterol Xinafoate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 39,700Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 208799 / DOSAGE - POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FLUTICASONE PROPIONATE(UNII: O2GMZ0LF5W)
    (FLUTICASONE - UNII:CUT2W21N7U)     		FLUTICASONE PROPIONATE55ug | 113ug | 232ug
    SALMETEROL XINAFOATE(UNII: 6EW8Q962A5)
    (SALMETEROL - UNII:2I4BC502BT)     		SALMETEROL14ug | 14ug | 14ug

    Inactive Ingredients

    Ingredient Name
    Teva Respiratory, LLC
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)